STOP-AMDR

In Kenya, STOP-AMDR supports a phased national rollout of multiple first-line therapies, beginning in four counties. The approach introduces artesunate-pyronaridine and later rotates to dihydroartemisinin-piperaquine, while strengthening planning, provider training, reporting tools, and national malaria case-management guidance.




